Temsirolimus and Perifosine in Treating Patients With Recurrent or Progressive Malignant Glioma

Clinical trial NCT01051557 · COMPLETED

Trial details

NCT number: NCT01051557
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Adult Anaplastic Astrocytoma Adult Anaplastic Oligodendroglioma Adult Diffuse Astrocytoma Adult Giant Cell Glioblastoma Adult Glioblastoma Adult Gliosarcoma Adult Mixed Glioma Adult Oligodendroglioma Recurrent Adult Brain Neoplasm

Start date: 2010-01-27
Primary completion: 2018-11-16
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.